Literature DB >> 22328803

Cyclosporine Treatment of Intractable Colitis in Chronic Granulomatous Disease.

Wanda Phipatanakul1, Jerry A Winkelstein, Alan M Lake.   

Abstract

Entities:  

Year:  2009        PMID： 22328803      PMCID： PMC3276651          DOI： 10.1089/pai.2000.14.125

Source DB:  PubMed          Journal:  Pediatr Asthma Allergy Immunol        ISSN： 0883-1874


× No keyword cloud information.
  6 in total

1.  Gastrointestinal manifestations of chronic granulomatous disease.

Authors:  M E Ament; H D Ochs
Journal:  N Engl J Med       Date:  1973-02-22       Impact factor: 91.245

2.  Colitis in chronic granulomatous disease.

Authors:  S L Werlin; M J Chusid; J Caya; H W Oechler
Journal:  Gastroenterology       Date:  1982-02       Impact factor: 22.682

3.  Treatment of intractable gastrointestinal manifestations of chronic granulomatous disease with cyclosporine.

Authors:  J R Rosh; H B Tang; L Mayer; G Groisman; S K Abraham; A Prince
Journal:  J Pediatr       Date:  1995-01       Impact factor: 4.406

4.  Effects of cyclosporine or FK506 in chronic colitis.

Authors:  S Aiko; E M Conner; J A Fuseler; M B Grisham
Journal:  J Pharmacol Exp Ther       Date:  1997-02       Impact factor: 4.030

5.  Cyclosporine in severe ulcerative colitis refractory to steroid therapy.

Authors:  S Lichtiger; D H Present; A Kornbluth; I Gelernt; J Bauer; G Galler; F Michelassi; S Hanauer
Journal:  N Engl J Med       Date:  1994-06-30       Impact factor: 91.245

Review 6.  Chronic granulomatous disease: the solving of a clinical riddle at the molecular level.

Authors:  J T Curnutte
Journal:  Clin Immunol Immunopathol       Date:  1993-06
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.